Summary
This prediction is currently active. With a performance of -5.13%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 13.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | -4.399% | -4.399% |
| iShares Core DAX® | -0.681% | -4.853% |
| iShares Nasdaq 100 | -0.033% | 2.862% |
| iShares Nikkei 225® | -0.536% | -5.024% |
| iShares S&P 500 | -0.211% | 0.925% |
Comments by UBS_Group_AG for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its price target lowered by analysts at UBS Group AG from $26.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for ALT provided by MarketBeat